We are live on
!
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Rambus
RMBS
$9.7B
| $485K | ﹤0.01% |
+5,634
| New | +$562K |
2026 Q1
0 quarters
|
|
627
IDEAYA Biosciences
IDYA
$3.17B
| $483K | ﹤0.01% |
+14,501
| New | +$486K |
2026 Q1
0 quarters
|
|
628
United States Natural Gas Fund
UNG
$506M
| $480K | ﹤0.01% |
40,943
-11,539
| -22% | -$142K |
2025 Q4
1 quarter
|
|
629
Constellium
CSTM
$3.51B
| $478K | ﹤0.01% |
+19,451
| New | +$463K |
2026 Q1
0 quarters
|
|
630
Harmony Gold Mining
HMY
$10.7B
| $478K | ﹤0.01% |
+31,079
| New | +$614K |
2026 Q1
0 quarters
|
|
631
Daqo New Energy
DQ
$711M
| $478K | ﹤0.01% |
22,456
+9,116
| +68% | +$222K |
2023 Q4
9 quarters
|
|
632
Tidewater
TDW
$3.92B
| $477K | ﹤0.01% |
5,713
-1,918
| -25% | -$133K |
2024 Q4
5 quarters
|
|
633
PUT
Lucid Motors
LCID
$1.27B
| $477K | ﹤0.01% |
50,000
-235,000
| -82% | -$2.44M |
2025 Q3
2 quarters
|
|
634
General Mills
GIS
$17.6B
| $475K | ﹤0.01% |
12,768
+2,090
| +20% | +$90.8K |
2025 Q4
1 quarter
|
|
635
TransDigm Group
TDG
$63.4B
| $475K | ﹤0.01% |
+410
| New | +$537K |
2026 Q1
0 quarters
|
|
636
PUT
Uber
UBER
$144B
| $475K | ﹤0.01% |
6,600
| – | – |
2025 Q3
2 quarters
|
|
637
Workday
WDAY
$45.8B
| $473K | ﹤0.01% |
+3,639
| New | +$578K |
2026 Q1
0 quarters
|
|
638
Ciena
CIEN
$48B
| $472K | ﹤0.01% |
+1,215
| New | +$372K |
2026 Q1
0 quarters
|
|
639
Cheniere Energy
LNG
$58.9B
| $470K | ﹤0.01% |
+1,655
| New | +$382K |
2026 Q1
0 quarters
|
|
640
GE Aerospace
GE
$329B
| $469K | ﹤0.01% |
1,653
+971
| +142% | +$305K |
2025 Q2
3 quarters
|
|
641
Syndax Pharmaceuticals
SNDX
$1.16B
| $469K | ﹤0.01% |
20,060
+5,000
| +33% | +$109K |
2025 Q4
1 quarter
|
|
642
PUT
Palantir
PLTR
$450B
| $468K | ﹤0.01% |
3,200
-2,400
| -43% | -$367K |
2025 Q2
3 quarters
|
|
643
Acadia Healthcare
ACHC
$2.82B
| $468K | ﹤0.01% |
+20,000
| New | +$362K |
2026 Q1
0 quarters
|
|
644
iShares MSCI Chile ETF
ECH
$952M
| $467K | ﹤0.01% |
11,755
+4,255
| +57% | +$182K |
2025 Q4
1 quarter
|
|
645
iShares Core MSCI Total International Stock ETF
IXUS
$57.9B
| $465K | ﹤0.01% |
5,370
+56
| +1% | +$4.99K |
2025 Q3
2 quarters
|
|
646
Kopin
KOPN
$621M
| $465K | ﹤0.01% |
206,600
+24,600
| +14% | +$59.6K |
2025 Q3
2 quarters
|
|
647
monday.com
MNDY
$3.79B
| $462K | ﹤0.01% |
6,680
+3,525
| +112% | +$338K |
2025 Q3
2 quarters
|
|
648
Digital Realty Trust
DLR
$65.5B
| $460K | ﹤0.01% |
2,550
-855
| -25% | -$146K |
2025 Q4
1 quarter
|
|
649
State Street SPDR S&P Biotech ETF
XBI
$9.58B
| $458K | ﹤0.01% |
+3,588
| New | +$448K |
2026 Q1
0 quarters
|
|
650
Elevance Health
ELV
$93.1B
| $458K | ﹤0.01% |
1,565
+395
| +34% | +$130K |
2025 Q3
2 quarters
|
|
Similar funds
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.